CoChat
Sign Up
Cited by 50

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Directing LRRK2 to membranes of the endolysosomal pathway triggers RAB phosphorylation and JIP4 recruitment

Kluss, Jillian H., Bonet-Ponce, Luis, Lewis, Patrick A., Cookson, Mark R.·2022·Neurobiology of Disease
DOI 10.1016/j.nbd.2022.105769PMC PMC9665168
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.nbd.2022.105769

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 47

  1. Babbey, 2006, Rab10 regulates membrane transport through early endosomes of polarized Madin-Darby canine kidney cells, Mol. Biol. Cell, 17, 3156, 10.1091/mbc.e05-08-0799 · DOI · Paper page
  2. Beilina, 2014, Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease, Proc. Natl. Acad. Sci. U. S. A., 111, 2626, 10.1073/pnas.1318306111 · DOI · Paper page
  3. Beilina, 2020, The Parkinson’s disease protein LRRK2 interacts with the GARP complex to promote retrograde transport to the trans-Golgi network, Cell Rep., 31, 10.1016/j.celrep.2020.107614 · DOI · Paper page
  4. Berger, 2010, Membrane localization of LRRK2 is associated with increased formation of the highly active LRRK2 dimer and changes in its phosphorylation, Biochemistry, 49, 5511, 10.1021/bi100157u · DOI
  5. Boecker, 2021, Increased LRRK2 kinase activity alters neuronal autophagy by disrupting the axonal transport of autophagosomes, Curr. Biol. CB, 31, 2140, 10.1016/j.cub.2021.02.061 · DOI
  6. Bonet-Ponce, 2020, LRRK2 mediates tubulation and vesicle sorting from lysosomes, Sci. Adv., 6, 10.1126/sciadv.abb2454 · DOI
  7. Civiero, 2012, Biochemical characterization of highly purified leucine-rich repeat kinases 1 and 2 demonstrates formation of homodimers, PLoS One, 7, 10.1371/journal.pone.0043472 · DOI
  8. Cookson, 2010, The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson’s disease, Nat. Rev. Neurosci., 11, 791, 10.1038/nrn2935 · DOI
  9. Efergan, 2016, Rab12 regulates retrograde transport of mast cell secretory granules by interacting with the RILP-dynein complex, J. Immunol. Baltim. Md, 1950, 1091
  10. Eguchi, 2018, LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis, Proc. Natl. Acad. Sci. U. S. A., 115, E9115, 10.1073/pnas.1812196115 · DOI
  11. Etoh, 2019, Rab10 regulates tubular endosome formation through KIF13A and KIF13B motors, J. Cell Sci., 132, jcs226977, 10.1242/jcs.226977 · DOI · Paper page
  12. Fujimoto, 2018, Parkinson’s disease-associated mutant LRRK2 phosphorylates Rab7L1 and modifies trans-Golgi morphology, Biochem. Biophys. Res. Commun., 495, 1708, 10.1016/j.bbrc.2017.12.024 · DOI
  13. Funayama, 2005, An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family, Ann. Neurol., 57, 918, 10.1002/ana.20484 · DOI
  14. Gilks, 2005, A common LRRK2 mutation in idiopathic Parkinson’s disease, Lancet, 365, 415
  15. Gomez, 2019, Membrane association but not identity is required for LRRK2 activation and phosphorylation of Rab GTPases, J. Cell Biol., 218, 4157, 10.1083/jcb.201902184 · DOI · Paper page
  16. Greggio, 2008, The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation, J. Biol. Chem., 283, 16906, 10.1074/jbc.M708718200 · DOI
  17. Hammond, 2014, A novel probe for phosphatidylinositol 4-phosphate reveals multiple pools beyond the Golgi, J. Cell Biol., 205, 113, 10.1083/jcb.201312072 · DOI · Paper page
  18. Herbst, 2020, LRRK2 activation controls the repair of damaged endomembranes in macrophages, EMBO J., e104494
  19. Homma, 2021, Rab family of small GTPases: an updated view on their regulation and functions, FEBS J., 288, 36, 10.1111/febs.15453 · DOI
  20. Iida, 2005, Identification of rab12 as a vesicle-associated small GTPase highly expressed in Sertoli cells of rat testis, Mol. Reprod. Dev., 71, 178, 10.1002/mrd.20294 · DOI
  21. Iwaki, 2020, Penetrance of Parkinson’s disease in LRRK2 p.G2019S carriers is modified by a polygenic risk score, Mov. Disord. Off. J. Mov. Disord. Soc., 10.1002/mds.27974 · DOI
  22. Kalogeropulou, 2020, Endogenous Rab29 does not impact basal or stimulated LRRK2 pathway activity, Biochem. J., 477, 4397, 10.1042/BCJ20200458 · DOI
  23. Klein, 2009, Homo- and heterodimerization of ROCO kinases: LRRK2 kinase inhibition by the LRRK2 ROCO fragment, J. Neurochem., 111, 703, 10.1111/j.1471-4159.2009.06358.x · DOI
  24. Kluss, 2019, LRRK2 links genetic and sporadic Parkinson’s disease, Biochem. Soc. Trans., BST20180462
  25. Kumari, 2009, LRRK2 in Parkinson’s disease: genetic and clinical studies from patients, FEBS J., 276, 6455, 10.1111/j.1742-4658.2009.07344.x · DOI · Paper page
  26. Kuwahara, 2016, LRRK2 and RAB7L1 coordinately regulate axonal morphology and lysosome integrity in diverse cellular contexts, Sci. Rep., 6, 29945, 10.1038/srep29945 · DOI · Paper page
  27. Lee, 2017, Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry: LRRK2 mutation in non-Ashkenazi Jewish ancestry, Mov. Disord., 32, 1432, 10.1002/mds.27059 · DOI
  28. Liberles, 1997, Inducible gene expression and protein translocation using nontoxic ligands identified by a mammalian three-hybrid screen, Proc. Natl. Acad. Sci. U. S. A., 94, 7825, 10.1073/pnas.94.15.7825 · DOI
  29. Liu, 2013, Myosin Vb controls biogenesis of post-Golgi Rab10 carriers during axon development, Nat. Commun., 4, 2005, 10.1038/ncomms3005 · DOI
  30. Liu, 2018, LRRK2 phosphorylates membrane-bound Rabs and is activated by GTP-bound Rab7L1 to promote recruitment to the trans-Golgi network, Hum. Mol. Genet., 27, 385, 10.1093/hmg/ddx410 · DOI · Paper page
  31. Mamais, 2021, Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia, PLoS Biol., 19, 10.1371/journal.pbio.3001480 · DOI
  32. Matsui, 2011, Small GTPase Rab12 regulates constitutive degradation of transferrin receptor, Traffic Cph. Den., 12, 1432, 10.1111/j.1600-0854.2011.01240.x · DOI
  33. Nalls, 2019, Identification of novel risk loci, causal insights, and heritable risk for Parkinson’s disease: a meta-analysis of genome-wide association studies, Lancet Neurol., 18, 1091, 10.1016/S1474-4422(19)30320-5 · DOI · Paper page
  34. Paisán-Ruíz, 2004, Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease, Neuron, 44, 595, 10.1016/j.neuron.2004.10.023 · DOI
  35. Purlyte, 2018, Rab29 activation of the Parkinson’s disease-associated LRRK2 kinase, EMBO J., 37, 1, 10.15252/embj.201798099 · DOI · Paper page
  36. Robinson, 2010, Rapid inactivation of proteins by rapamycin-induced rerouting to mitochondria, Dev. Cell, 18, 324, 10.1016/j.devcel.2009.12.015 · DOI
  37. Ryan, 2017, A human microglia-like cellular model for assessing the effects of neurodegenerative disease gene variants, Sci. Transl. Med., 9, 10.1126/scitranslmed.aai7635 · DOI
  38. Rydell, 2014, Rab12 localizes to Shiga toxin-induced plasma membrane invaginations and controls toxin transport, Traffic Cph. Den., 15, 772, 10.1111/tra.12173 · DOI
  39. Sheng, 2012, Ser1292 autophosphorylation is an indicator of LRRK2 kinase activity and contributes to the cellular effects of PD mutations, Sci. Transl. Med., 4, 164ra161, 10.1126/scitranslmed.3004485 · DOI
  40. Singleton, 2011, A generalizable hypothesis for the genetic architecture of disease: pleomorphic risk loci, Hum. Mol. Genet., 20, R158, 10.1093/hmg/ddr358 · DOI
  41. Steger, 2016, Phosphoproteomics reveals that Parkinson’s disease kinase LRRK2 regulates a subset of Rab GTPases, eLife, 5
  42. Štimac, 2021, Dynamin inhibitors prevent the establishment of the cytomegalovirus assembly compartment in the early phase of infection, Life Basel Switz., 11, 876
  43. van Unen, 2015, Plasma membrane restricted RhoGEF activity is sufficient for RhoA-mediated actin polymerization, Sci. Rep., 5, 14693, 10.1038/srep14693 · DOI
  44. Varnai, 2006, Rapidly inducible changes in phosphatidylinositol 4,5-bisphosphate levels influence multiple regulatory functions of the lipid in intact living cells, J. Cell Biol., 175, 377, 10.1083/jcb.200607116 · DOI · Paper page
  45. Wang, 2014, A role of Rab29 in the integrity of the trans-Golgi network and retrograde trafficking of Mannose-6-phosphate receptor, PLoS One, 9
  46. West, 2014, Ten years and counting: moving leucine-rich repeat kinase 2 inhibitors to the clinic, Mov. Disord. Off. J. Mov. Disord. Soc.
  47. Zimprich, 2004, Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology, Neuron, 44, 601, 10.1016/j.neuron.2004.11.005 · DOI

Cited by

Sorted by citations

Metadata

Authors
Kluss, J. H., Bonet-Ponce, L., Lewis, P. A., & Cookson, M. R.
Venue
Neurobiology of Disease
Publisher
Elsevier BV
Published
2022-08
Volume
170
Pages
105769
ISSN
0969-9961
DOI
10.1016/j.nbd.2022.105769
PMC
PMC9665168
Cited by
50
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review